Identification of STAT5B as a biomarker associated with prognosis and immune infiltration in breast cancer
Open Access
- 3 March 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (9) , e32972
Abstract
Background: Breast invasive cancer (BRCA) is the most common malignancy and the second leading cause of malignancy death among women. Signal transducers and activators of transcription (STAT) family played a vital role in regulating certain biological processes and could serve as biomarkers for many diseases or cancers. Methods: The expression, prognostic value, and clinical functions of STAT family in BRCA were evaluated with several bioinformatics web portals. Results: The expression of STAT5A/5B were downregulated in BRCA in subgroup analyses based on race, age, gender, race, subclasses, tumor histology, menopause status, nodal metastasis status, and TP53 mutation. BRCA patients with high STAT5B expression had a better overall survival, relapse free survival, MDFS and post progression survival. STAT5B expression level can impact the prognosis in BRCA patients with positive PR status, negative Her2 status and wild type TP53. Moreover, STAT5B was positively correlated with immune cell infiltration and the level of immune biomarkers. Drug sensitivity revealed that low STAT5B expression was resistant to the many small molecules or drugs. Functional enrichment analysis revealed that STAT5B was involved in adaptive immune response, translational initiation, JAK-STAT signaling pathway, Ribosome, NF-kappa B signaling pathway and Cell adhesion molecules. Conclusions: STAT5B was a biomarker associated with prognosis and immune infiltration in breast cancer.Keywords
This publication has 37 references indexed in Scilit:
- Breast cancer statistics, 2015: Convergence of incidence rates between black and white womenCA: A Cancer Journal for Clinicians, 2015
- The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenograftsBMC Cancer, 2015
- Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast CancerClinical Cancer Research, 2015
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patientsAnnals of Oncology, 2014
- Differential Expression of STAT1 and p21 Proteins Predicts Pancreatic Cancer Progression and PrognosisPancreas, 2014
- CD4+ follicular helper T cell infiltration predicts breast cancer survivalJournal of Clinical Investigation, 2013
- Triple-Negative Breast CancerNew England Journal of Medicine, 2010
- Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cellsOncogene, 2004